Cardiac gene therapy stands at the forefront of revolutionary advancements in cardiovascular medicine, presenting a transformative approach to address a spectrum of heart-related challenges. This cutting-edge therapeutic method involves the precise introduction of specific genes into the cardiac system, aiming to rectify genetic anomalies, optimize myocardial performance, and impede the progression of various cardiac conditions. Through innovative gene delivery systems, researchers are delving into the possibilities of targeting conditions like arrhythmias and ischemic heart disease, paving the way for tailored interventions that go beyond traditional treatments. The dynamic landscape of cardiac gene therapy underscores a new era in cardiac care, offering a glimpse into the potential for highly individualized and impactful interventions that could redefine the future of cardiovascular health. As the field continues to evolve, the prospect of reshaping the landscape of cardiac medicine through gene-based therapies emerges as an exciting avenue of exploration and progress.
Title : Complete heart block and persistent left SVC: A pacing challenge after AV canal repair
Moataz Taha Mahmoud, Madinah Cardiac Center, Saudi Arabia
Title : Chemical detergent anionic surfactant-inducing dry cardiomyopathy (Yasser's cardiomyopathy) with parallel pupils/CXR phenomenon (Yasser's ophthalmic phenomenon), up-down Yasser's alternance, S1Q3 flat T3 pattern - Dramatic response to honey with possible cardiac regeneration - A case report
Yasser Mohammed Hassanain Elsayed, Egyptian Ministry of Health, Egypt
Title : Stabilization of molecular structures in red blood cell membrane by magnetite nanoparticles (ICNB) during storage
Andrey Belousov, Laboratory of Applied Nanotechnology of Belousov and Kharkiv National Medical University, Ukraine